Pricing Log in Create free account

Innate Pharma S.A. Sponsored ADR (IPHA) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

Innate Pharma S.A. Sponsored ADR and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Innate Pharma S.A. Sponsored ADR and Zentalis Pharmaceuticals, Inc. are of similar size ($162.8M and $160.9M). Zentalis Pharmaceuticals, Inc. has the higher net margin (0.00% vs −99.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, Innate Pharma S.A. Sponsored ADR leads on 6 and Zentalis Pharmaceuticals, Inc. on 3.

Valuation

Metric IPHA ZNTL Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 0.85 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.34 0.66
EV/Sales 0.12 n/m 9.02
Earnings yield (81.01%) (113.37%) (32.88%)
Free cash flow yield 0.00% (104.34%) (23.13%)

Profitability

Metric IPHA ZNTL Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (99.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (66.75%) (51.96%)
Return on assets 0.00% (49.22%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IPHA ZNTL Biotechnology median
Revenue growth (TTM) (4.17%) — 6.76%
EPS growth (last fiscal year) 6.06% 18.03% 29.88%
Revenue growth, 5-year CAGR (33.86%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IPHA ZNTL Biotechnology median
Debt to equity (0.50) 0.00 0.00
Current ratio 0.60 4.82 4.97
Net debt to EBITDA 0.22 1.59 1.01

Dividend

Metric IPHA ZNTL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IPHA ZNTL Biotechnology median
Market cap 160.85m 162.84m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack